Epizyme, Inc. EPZM
1.47 +1.47
Day range unavailable
52-week range unavailable
Ownership
Held by insiders 0.58%
Held by institutions 81.05%
Float held by institutions 81.52%
Institutions 139
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RP Management, LLC | 18.91% | 31,841,394 | 46.81M | Jun 29, 2022 |
| Primecap Management Company | 9.88% | 16,642,727 | 24.46M | Jun 29, 2022 |
| Blackrock Inc. | 6.40% | 10,778,038 | 15.84M | Mar 30, 2022 |
| Vanguard Group, Inc. (The) | 4.48% | 7,540,469 | 11.08M | Jun 29, 2022 |
| Rock Springs Capital Management, LP | 4.32% | 7,267,696 | 10.68M | Mar 30, 2022 |
| Palo Alto Investors Lp | 4.02% | 6,774,541 | 9.96M | Mar 30, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Primecap Odyssey Aggressive Growth Fund | 6.38% | 10,744,756 | 15.79M | Jun 29, 2022 |
| Primecap Odyssey Growth Fund | 2.86% | 4,821,843 | 7.09M | Jun 29, 2022 |
| Vanguard Total Stock Market Index Fund | 2.15% | 3,626,874 | 5.33M | Mar 30, 2022 |
| iShares Russell 2000 ETF | 1.79% | 3,016,455 | 4.43M | May 30, 2022 |
| Fidelity Select Portfolios - Biotechnology | 1.56% | 2,621,335 | 3.85M | May 30, 2022 |
| Vanguard Extended Market Index Fund | 1.50% | 2,519,574 | 3.70M | Mar 30, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AGARWAL SHEFALI | Officer | Conversion of Exercise of derivative security | Aug 8, 2022 | 285,562 |
| BATE KENNETH M | Director | Stock Award(Grant) | May 16, 2022 | 17,054 |
| BEAULIEU JOSEPH | Officer | Conversion of Exercise of derivative security | Aug 8, 2022 | 51,099 |
| BEVERIDGE ROY A M.D. | Director | Stock Award(Grant) | Jun 29, 2022 | 46,037 |
| BOGLE GRANT C | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 8, 2022 | 259,170 |
| CONROY KEVIN T | Director | Stock Award(Grant) | Jun 29, 2022 | 62,318 |